Austin biotech firm, Aeglea, aims to raise $86 million for its IPO. The company, founded by UT professor, George Georgiou, develops drug therapies to fight cancer. http://www.statesman.com/news/business/austin-firm-aeglea-biotherapeutics-sets-ipo-aims-t/nmfZN/ (via Statesman)










